|
|
Volumn 26, Issue 10, 2007, Pages 1799-1800
|
|
Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ETANERCEPT;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INFLIXIMAB;
INSULIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PREDNISOLONE;
TRIACYLGLYCEROL;
ANTIRHEUMATIC AGENT;
IMMUNOGLOBULIN G;
LIPID;
MONOCLONAL ANTIBODY;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
UNCLASSIFIED DRUG;
BODY MASS;
BODY WEIGHT;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
CLINICAL ASSESSMENT TOOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DISEASE ACTIVITY INDEX OF 28 JOINT SCORE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GLUCOSE BLOOD LEVEL;
HUMAN;
INSULIN BLOOD LEVEL;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
LETTER;
LIPID ANALYSIS;
PRIORITY JOURNAL;
QUANTITATIVE STUDY;
RHEUMATOID ARTHRITIS;
SCORING SYSTEM;
TREATMENT RESPONSE;
TRIACYLGLYCEROL BLOOD LEVEL;
ATHEROSCLEROSIS;
CHEMISTRY;
DRUG ANTAGONISM;
METHODOLOGY;
NOTE;
PROSPECTIVE STUDY;
RHEUMATOLOGY;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
ATHEROSCLEROSIS;
HUMANS;
IMMUNOGLOBULIN G;
INSULIN RESISTANCE;
LIPIDS;
PROSPECTIVE STUDIES;
RECEPTORS, TUMOR NECROSIS FACTOR;
RHEUMATOLOGY;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 38449102126
PISSN: 07703198
EISSN: None
Source Type: Journal
DOI: 10.1007/s10067-007-0702-2 Document Type: Letter |
|
Times cited : (32)
|
|
References (6)
|
